Randomized study of phentolamine mesylate for reversal of local anesthesia

Journal of Dental Research

Volumn 87, Issue 7, 2008, Pages 635-639

  Laviola, M ^a   McGavin, S K ^b   Freer, G A ^b   Plancich, G ^a   Woodbury, S C ^b   Marinkovich, S ^a   Morrison, R ^a   Reader, A ^c   Rutherford, R B ^d   Yagiela, J A ^e  

^a Northwest Kinetics   (United States)

^b Jean Brown Research   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Novalar Pharmaceuticals   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dentistry; Local anesthesia; Phentolamine; Reversal

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; LOCAL ANESTHETIC AGENT; PHENTOLAMINE; VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DENTAL ANESTHESIA; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIP; MALE; METHODOLOGY; MIDDLE AGED; MOUTH; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SENSATION; TIME; TOUCH;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ANESTHESIA, DENTAL; ANESTHETICS, LOCAL; CHILD; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG INTERACTIONS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIP; MALE; MIDDLE AGED; MOUTH; PHENTOLAMINE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; REFERENCE VALUES; SENSATION; TIME FACTORS; TOUCH; VASOCONSTRICTOR AGENTS;

EID: 47649112564     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808700717     Document Type: Article

References (13)

1. Abel PW, Piascik MT (2004). Adrenergic agonists. In: Pharmacology and therapeutics for dentistry. 5th ed. Yagiela JA, Dowd FJ, Neidle EA, editors. St. Louis, MO: Elsevier Mosby, pp. 98-112.
2. Bey D, El-Chaar GM, Bierman F, Valderrama E (1998). The use of phentolamine in the prevention of dopamine-induced tissue extravasation. J Crit Care 13:13-20.
3. Collett D (1994). Modeling survival data in medical research. London: Chapman and Hall.
4. Cooper BE (1989). High-dose phentolamine for extravasation of pressors. Clin Pharm 8:689.
5. Edwall B, Gazelius B, Fazekas A, Theodorsson-Norheim E, Lundberg JM (1985). Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat. Acta Physiol Scand 125:253-264.
6. Kerezoudis NP, Olgart L, Edwall L, Gazelius B, Nomikos GG (1992). Activation of sympathetic fibres in the pulp by electrical stimulation of rat incisor teeth. Arch Oral Biol 37:1013-1019.
7. Kerezoudis NP, Funato A, Edwall L, Olgart L (1993). Activation of sympathetic nerves exerts an inhibitory influence on afferent nerve-induced vasodilation unrelated to vasoconstriction in rat dental pulp. Acta Physiol Scand 147:27-35.
8. Koss MC (2002). Differential neural activation of vascular alpha-adrenoceptors in oral tissues of cats. Eur J Pharmacol 440:53-59.
9. Maguire WM, Reisdorff EJ, Smith D, Wiegenstein JG (1990). Epinephrine-induced vasospasm reversed by phentolamine digital block. Am J Emerg Med 8:46-47.
10. Malamed SF (2004). Handbook of local anesthesia. 5th ed. St. Louis, MO: Elsevier Mosby.
11. Siwy BK, Sadove AM (1987). Acute management of dopamine infiltration injury with Regitine. Plast Reconstr Surg 80:610-612.
12. Stetson JB, Reading GP (1977). Avoidance of vascular complications associated with the use of dopamine. Can Anaesth Soc J 24:727-733.
13. Subhani M, Sridhar S, DeCristofaro JD (2001). Phentolamine use in a neonate for the prevention of dermal necrosis caused by dopamine: a case report. J Perinatol 21:324-326.